News
News
Small Cap ESG Investing: Making a Positive Impact with High Returns
As the ESG investing trend continues to gain momentum, more small cap companies are expected to emerge as leaders in...
Read moreDetails
Easterly Government Properties: Is The Recent Analyst Downgrade For Reddit’s Favorite REIT Justified?
RBC Capital Markets analyst Michael Carroll downgraded the commercial Real Estate Investment Trust (REIT) from 'Sector Perform' to 'Underperform' on...
Read moreDetails
Alteryx Inc. Up For Sale: What Value Can The Data Analytics Player Fetch From The Market?
News reports have indicated that its management is exploring a potential sale of the company.
Read moreDetails
Health & Wellness Trends: Transforming the Healthcare Industry and Investment Landscape
Health consciousness is on the rise due to an aging population, consumer demand for healthier alternatives, and a renewed desire...
Read moreDetails
Yext Inc.: Does The Recent Stock Meltdown Point To A Buying Signal Or Is It Time To Jump Ship?
Despite the company meeting or even slightly exceeding analysts' expectations in its latest earnings report and raising its guidance, it...
Read moreDetails
Long-term Survival Data from Longeveron’s ELPIS 1 Trial Accepted for Presentation at the 2023 Scientific Sessions of the American Heart Association
Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions...
Read moreDetails
Longeveron to Participate in the 149th Annual National Investment Banking Association Conference
Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions...
Read moreDetails
NextGen Healthcare: A Goldmine for M&A Arbitrageurs in the Healthcare Landscape?
Speculation around the company's future has sent ripples across the market, especially after its stock price surged in response to...
Read moreDetails
The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
NanoViricides, Inc. (NYSE American: NNVC) a leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
Read moreDetailsLongeveron Announces Achievement of Surpassing 50% Enrollment Threshold in Phase 2 ELPIS II Study of Lomecel-BTM in Hypoplastic Left Heart Syndrome
Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, announced today...
Read moreDetails